Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Ovarian Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01570582
What this trial is testing

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
Korean Gynecologic Oncology Group 314
Not applicableUnknownNCT03134482
What this trial is testing

Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS

Who this might be right for
No Condition
CHA University 240
Large-scale testing (Phase 3)Study completedNCT02518191
What this trial is testing

Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity

Who this might be right for
Breast Cancer
Xiangyun Zong 345
Not applicableUnknownNCT05640024
What this trial is testing

Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

Who this might be right for
Ovarian Cancer
Yonsei University 54
Large-scale testing (Phase 3)UnknownNCT03278717
What this trial is testing

Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
University College, London 330
Large-scale testing (Phase 3)UnknownNCT01087268
What this trial is testing

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Who this might be right for
Bladder CancerCervical CancerColorectal Cancer+9 more
Royal Marsden NHS Foundation Trust 75
Testing effectiveness (Phase 2)Study completedNCT00193297
What this trial is testing

Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma

Who this might be right for
Ovary Cancer
SCRI Development Innovations, LLC 50
Early research (Phase 1)Study completedNCT01469793
What this trial is testing

DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Genentech, Inc. 71
Testing effectiveness (Phase 2)WithdrawnNCT06393751
What this trial is testing

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02054351
What this trial is testing

Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)

Who this might be right for
Ovarian Cancer
Ganymed Pharmaceuticals GmbH 42
Not applicableNot Yet RecruitingNCT06838429
What this trial is testing

PARPi and Ovarian Cancer Survival

Who this might be right for
Epithelial Ovarian Cancer, Fallopian Tube or PeritoneumPARP Inhibitor
Shanghai Gynecologic Oncology Group 6,000
Not applicableUnknownNCT02744131
What this trial is testing

OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women

Who this might be right for
Polycystic Ovary Syndrome
Kar Clinic & Hospital Pvt. Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT07042802
What this trial is testing

LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Nanjing Leads Biolabs Co.,Ltd 180
Testing effectiveness (Phase 2)Looking for participantsNCT03878849
What this trial is testing

Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

Who this might be right for
Advanced Ovarian Cancer
Allarity Therapeutics 40
Early research (Phase 1)Ended earlyNCT01312376
What this trial is testing

Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer

Who this might be right for
Ovarian CarcinomaFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 18
Early research (Phase 1)Ended earlyNCT01485874
What this trial is testing

Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hoosier Cancer Research Network 11
Not applicableStudy completedNCT05769426
What this trial is testing

Health Risks and Barriers to Management Across the PCOS Lifespan

Who this might be right for
Polycystic Ovary SyndromeMenopause
The University of Texas Medical Branch, Galveston 49
Not applicableUnknownNCT05986838
What this trial is testing

Effect of Laser Puncture Versus Ultraviolet Radiation on Women With Polycystic Ovarian Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Cairo University 100
Testing effectiveness (Phase 2)Study completedNCT04840238
What this trial is testing

30000 IU Per Week Vitamin D Treatment in PCOS Patients

Who this might be right for
Polycystic Ovary SyndromeVitamin D Deficiency
Semmelweis University 115
Not applicableStudy completedNCT03379376
What this trial is testing

EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery

Who this might be right for
Female Reproductive System NeoplasmMalignant Female Reproductive System NeoplasmMalignant Uterine Neoplasm+4 more
Wake Forest University Health Sciences 10
Next Page